gip and glp 1 Indications for GLP-1/GIP RA Summary Sheet Beyond! GLP-1 and GIP in Type
Description
CHS Reports $70M Q4 Loss : Community Health Systems reported a $70 million loss in Q4 2024
Study methods: Adult patients who were taking GLP-1s and scheduled to receive anesthesia at 3 hospitals between June 30, 2023, and August 15, 2024, were evaluated via preoperative point-of-care gastric ultrasonography (GUS)
doi: 10.1136/gutjnl-2020-323617 91 NicolucciA.CharbonnelB.GomesM
Pfizer - Partnership (December 2025): Pfizer struck a $2 billion deal with YaoPharma to develop and commercialize a phase 1 small-molecule GLP-1 receptor agonist [1]
& Guy S) 12891301 (Academic Press, 2013)
